EBITDA of Recipharm 2009-2021
The EBITDA of Swedish pharmaceutical company Recipharm generally increased, but with some fluctuations, during the period from 2009 to 2021. In 2009, EBITDA amounted to 61.1 million Swedish kronor, and in 2021, the company reported the highest EBITDA so far, with some 2.08 billion Swedish kronor. Recipharm is a Swedish pharmaceutical contract development and manufacturing organization, founded in Stockholm in 1995.